mounjaro tirzepatide 10mg more effective in blood sugar control and weight loss than semaglutide, meta-analysis finds Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Prefilled Syringes are a type of medication used to treat type 2 diabetes MOUNJARO 10 MG / 0.5

In England, this would be uncommon as, at time of publishing, NHS England allows the medication to be prescribed in primary care under a funding variation 6 for people with the following: Initial BMI 35 kg/m 2 (as of June 2026) and at least four of the following long-term conditions: Hypertension Dyslipidaemia Established cardiovascular disease Obstructive sleep apnoea (Type 2 diabetes) HSC obesity services are expected to commence in Northern Ireland in autumn 2026

So, if all this has you interested in peptides for weight loss, you've come to the right place

The topic requires significantly more research before definitive conclusions can be drawn

The MHRA Summary of Product Characteristics for tirzepatide advises caution in this population, and alternative therapies should be considered

Scientists may glean more hints in future tirzepatide trials